USPTO serial 79449525
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research and development relating to stem cell therapy; research and development relating to stem cells in bone marrow; research and development relating to cell-based therapies; research and development relating to bone marrow donations and regenerative medicine | ACTIVE | — |
| 044 | Medical services relating to the removal, treatment and processing of bone marrow; physician services; medical care; conducting of medical examinations, conducting of operations and medical treatments; medical services relating to the collection, treatment, implantation and processing of stem cells; medical services, namely conducting of stem cell therapies; physicians' and medical services relating to orthopaedic surgery; medical services in the field of orthopaedics; physicians' and medical services in the field of regenerative medicine; physicians' and medical services in the field of neurology, internal medicine and cardiology and/or dermatology; regenerative therapy | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 23, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 23, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 5, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 8, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |